Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task

Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task

Central diabetes insipidus (CDI) is a rare endocrine disease deriving from an insufficient production or secretion of anti-diuretic hormone. Recently, CDI has been reported as a rare side effect triggered by immune checkpoint inhibitors (ICI) in cancer patients. Despite its current rarity, CDI trigg...

Full description

Bibliographic Details
Main Authors: Agnese Barnabei, Lidia Strigari, Andrea Corsello, Rosa Maria Paragliola, Giovanni Maria Iannantuono, Roberto Salvatori, Salvatore Maria Corsello, Francesco Torino
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Endocrinology
Subjects:
central diabetes insipidus
immune checkpoint inhibitors
grading system
CTCAE
endocrine toxicities
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.840971/full

Similar Items

Similar Items